COSMO Pharmaceuticals NV/ NL0011832936 /
| 2024-05-16 5:12:02 PM | Chg. +0.10 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 73.50CHF | +0.14% | 538 Turnover: 39,699.40 |
-Bid Size: - | -Ask Size: - | 1.2 bill.CHF | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.07 EUR | -93.23% |
| EPS Diluted: | - EUR | -93.23% |
| Revenues per Share: | 5.95 EUR | -5.27% |
| Book Value per Share: | 26.25 EUR | -6.60% |
| Cash Flow per Share: | 2.31 EUR | 6.89% |
| Dividend per Share: | 2.00 EUR | 108.33% |
| Total | in mill. | |
| Revenues: | 96.72 EUR | -5.27% |
| Net Income: | 1.15 EUR | -93.34% |
| Operating Cash Flow: | 37.60 EUR | - |
| Cash and Cash Equivalents: | 50.28 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 1,053.97 | 767.61 |
| P/S Ratio: | 12.58 | 9.16 |
| P/BV ratio: | 2.85 | 2.08 |
| P/CF Ratio: | 32.36 | 23.57 |
| PEG: | -11.30 | -8.23 |
| Earnings Yield: | 0.09% | 0.13% |
| Dividend Yield: | 2.67% | 3.67% |
| Market Capitalization | ||
| Market Capitalization: | 1.2 bill. CHF | 820.6 mill. CHF |
| Free Float Market Cap.: | - CHF | - CHF |
| Market Cap. / Employee: | 3.86 mill. CHF | 2.65 mill. CHF |
| Shares Outstanding: | 16.26 mill. | |
Profitability
| Gross Profit Margin: | 59.33% |
| EBIT Margin: | 12.64% |
| Net Profit Margin: | 1.19% |
| Return on Equity: | 0.27% |
| Return on Assets: | 0.21% |
Financial Strength
| Liquidity I / Cash Ratio: | 216.96% |
| Liquidity II / Quick Ratio: | 339.76% |
| Liquidity III / Current Ratio: | 441.16% |
| Debt / Equity Ratio: | 29.81% |
| Dynam. Debt / Equity Ratio: | 338.33% |
Efficiency
| Employees: | 310 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 312,009.68 EUR |
| Net Income / Employee: | 3,700.00 EUR |
| Total Assets / Employee: | 1,787,032.26 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
